CD96 as a Potential Immune Regulator in Cancers

The discovery of CTLA-4 and PD-1 checkpoints has prompted scientific researchers and the pharmaceutical industry to develop and conduct extensive research on tumor-specific inhibitors. As a result, the list of potential immune checkpoint molecules is growing over time. Receptors for nectin and necti...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Shikai, Isayev, Orkhan, Werner, Jens, Bazhin, Alexandr V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866520/
https://www.ncbi.nlm.nih.gov/pubmed/36674817
http://dx.doi.org/10.3390/ijms24021303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866520/
https://www.ncbi.nlm.nih.gov/pubmed/36674817
http://dx.doi.org/10.3390/ijms24021303

Ejemplares similares